Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Fawad, Farooq"'
Publikováno v:
In IFAC PapersOnLine 2023 56(2):9147-9152
Autor:
Ashraf, Fawad Farooq, Mobeen, Surrayya, Khan, Hafiz Zeeshan Iqbal, Haydar, Muhammad Farooq, Riaz, Jamshed
Publikováno v:
In IFAC PapersOnLine 2023 56(2):360-365
Autor:
Mukesh Kumar, Ghulam Shabbir Shar, Rajesh Kumar, Abdul Hakeem Shaikh, Haroon Ishaque, Naveedullah Khan, Fawad Farooq, Tahir Saghir, Tariq Ashraf, Musa Karim
Publikováno v:
Indian Heart Journal, Vol 74, Iss 6, Pp 464-468 (2022)
Background: Primary percutaneous coronary intervention (PCI) is a recommended management strategy for patients with de novo ST-segment elevation myocardial infarction (STEMI). Still, the efficacy of primary PCI in-stent thrombosis (ST) induced STEMI
Externí odkaz:
https://doaj.org/article/54fa2b49e07a4a1db86fb7db4bf6ba49
Autor:
Kamran Ahmed Khan, Rajesh Kumar, Jehangir Ali Shah, Fawad Farooq, Quratulain Shaikh, Dileep Kumar, Jawaid Akbar Sial, Tahir Saghir, Abdul Samad Achakzai, Musa Karim
Publikováno v:
SAGE Open Medicine, Vol 10 (2022)
Objectives: No-reflow is a complication that frequently occurs after stenting during primary percutaneous coronary intervention. In this study, we focused on angiographic results and clinical outcomes after no-reflow in the left anterior descending (
Externí odkaz:
https://doaj.org/article/0c21457d0a2f45ba86f34ac0446ecd68
Autor:
Khan, Mohd. Fawad Farooq1 bobby.fawad1971@gmail.com, Afzal, Kamran2, Arif, S. H.3, Shahin, Shadma3
Publikováno v:
Indian Journal of Medical Research. Dec2022, Vol. 156 Issue 6, p750-755. 6p.
Autor:
Dileep, Kumar, Iftikhar, Ahmed, Fawaz, Bardooli, Tahir, Saghir, Jawaid Akbar, Sial, Kamran Ahmed, Khan, Fawad, Farooq, Tarique Shahzad, Chachar, Musa, Karim, Hitesh, Kumar, Reeta, Bai, Nadeem, Qamar
Publikováno v:
Cardiovascular Revascularization Medicine. 47:1-4
The aim of this study was to compare TIMI flow after administering intracoronary (IC) medications through various routes for the treatment of slow flow/no-reflow during primary PCI.Two independent parallel cohorts of the patients who underwent primar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e391808e443eb3b58ecd9ba45498f542
https://doi.org/10.1016/j.carrev.2022.09.014
https://doi.org/10.1016/j.carrev.2022.09.014
Publikováno v:
Journal of the Pakistan Medical Association (2020)
Abstract Objective: To determine the effect of Ivabradine in lowering heart rate and quality of life in chronic heart failure patients. Methods: The observational study was conducted in the out-patient department of the National Institute of Ca
Externí odkaz:
https://doaj.org/article/01f48e4846aa4a59a1ca8d96eada6128
Publikováno v:
Indian Journal of Medical Research. 156:750-755
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbfc06d73987bec8e798443ecaeeaea7
https://doi.org/10.4103/ijmr.ijmr_2504_19
https://doi.org/10.4103/ijmr.ijmr_2504_19
Publikováno v:
International Journal of Endorsing Health Science Research, Vol 5, Iss 4, Pp 12-16 (2017)
Background: Warfarin was used for decades to prevent stroke in high risk AF patients, recent guidelines and published data is recommending use of NOACs like Rivaroxaban as an alternative to Warfarin, Its use is increasing world over because of its pr
Externí odkaz:
https://doaj.org/article/bdee2924ee69492db9db137eed74e752
Publikováno v:
Pakistan Journal of Cardiovascular Intervention. 2:40-44
Background: Coronary artery anomalies are very rare congenital conditions. Rarely occurring but potentially fatal abnormalities of the coronary vasculature, abnormalities of the coronary arteries can cause significant cardiac events such as myocardia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a058ab4cd5e96f2966f0781983a0bde
https://doi.org/10.58889/pjcvi.2.40.44
https://doi.org/10.58889/pjcvi.2.40.44